Human Insulin Does Not Increase Prostate Cancer Risk in Taiwanese
نویسندگان
چکیده
منابع مشابه
Human Insulin Does Not Increase Bladder Cancer Risk
BACKGROUND Whether human insulin can induce bladder cancer is rarely studied. METHODS The reimbursement databases of all Taiwanese diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2004 and a total of 785,234 patients with type 2 diabetes were followed up for bladder cancer incidence until the end of 2009. Users of piogli...
متن کاملDoes zinc supplementation increase the risk of prostate cancer?
I n the United States, prostate cancer is the most commonly diagnosed cancer in men and the second leading cause of cancer deaths in this population. It is estimated that 220000 cases of prostate cancer will be diagnosed this year, and this is expected to increase with the expanding geriatric population. The etiology of prostate cancer is multifactorial. Genetic factors are important and contri...
متن کاملAdoption Does Not Increase the Risk of Mortality among Taiwanese Girls in a Longitudinal Analysis
Adopted children often experience health and well-being disadvantages compared to biological children remaining in their natal households. The degree of genetic relatedness is thought to mediate the level of parental investment in children, leading to poorer outcomes of biologically unrelated children. We explore whether mortality is related to adoption in a historical Taiwanese population wher...
متن کاملAssociation between Human Papillomavirus Infection and Risk of Prostate Cancer
Human papillomavirus (HPV) is one of the most common causes of sexually transmitted diseases worldwide and is the etiological agent of cervical and other anogenital malignancies. Since HPVs have been shown to possess oncogenic potential, an association between HPV infection and prostatic cancer (PCa) has been suggested. There are conflicting reports on the impact of HPV infection on the deve...
متن کاملFinasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.
Finasteride taken for 7 years in the Prostate Cancer Prevention Trial (PCPT) reduced the risk of prostate cancer by 25%, but with an apparent increased risk of high-grade disease. Subsequent analyses found that finasteride biases toward improved prostate cancer detection and accuracy in prostate cancer grading at biopsy. In our first analysis of the present study, we accounted for these biases ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Genitourinary Cancer
سال: 2014
ISSN: 1558-7673
DOI: 10.1016/j.clgc.2013.08.004